Table 1. Demographics, lipids and medication profiles of the study population stratified by sex.
| All patients (n=1,683) | Women n=1,096 (65%) | Men n=587 (35%) | p-value | |
| Age, years | 51 (42, 59) | 52 (44, 60) | 49 (39, 57) | <0.001 |
| Hypertension, n (%) | 729 (43) | 476 (44) | 253 (43) | 0.80 |
| Diabetes mellitus, n (%) | 156 (9) | 98 (9) | 58 (10) | 0.54 |
| Hyperlipidaemia, n (%) | 913 (54) | 583 (54) | 330 (56) | 0.27 |
| Tobacco smoking, n (%) | 200 (12) | 92 (9) | 108 (18) | <0.001 |
| Height, cm | 168 (162, 175) | 164 (160, 168) | 178 (173, 183) | <0.001 |
| Weight, kg | 81.0 (68.0, 95.2) | 74.0 (64.0, 88.5) | 91.0 (80.0, 103.0) | <0.001 |
| BMI, kg/m2 | 28.1 (24.4, 32.5) | 27.6 (23.7, 32.8) | 28.4 (25.5, 32.1) | 0.008 |
| Resting mean arterial pressure, mmHg | 98 (89, 108) | 99 (90, 109) | 96 (88, 105) | <0.001 |
| Resting heart rate, bpm | 71 (62, 80) | 73 (64, 82) | 67 (60, 77) | <0.001 |
| Lipid profiles | ||||
| Total cholesterol, mg/dl | 184 (157, 214) | 187 (163, 216) | 175 (148, 205) | <0.001 |
| Triglycerides, mg/dl | 110 (77, 167) | 106 (72, 154) | 125 (86, 188) | <0.001 |
| High-density lipoprotein, mg/dl | 51 (42, 63) | 56 (47, 69) | 43 (35, 50) | <0.001 |
| Low-density lipoprotein, mg/dl | 103 (81, 128) | 104 (81, 128) | 102 (78, 129) | 0.43 |
| Vasoactive medications | ||||
| Beta-blockers, n (%) | 479 (28) | 317 (29) | 162 (28) | 0.58 |
| Calcium channel blockers, n (%) | 538 (32) | 352 (32) | 186 (32) | 0.90 |
| Nitrates, n (%) | 626 (37) | 408 (37) | 218 (37) | 1.00 |
| Data presented as n (%) and median (interquartile range). p-value is for comparison between sexes. | ||||